We therefore undertook the present study to test whether the genetic variability of CACNA1E affects key metabolic phenotypes (beta cell function and insulin sensitivity, both assessed by state-of-art methods) in patients with newly diagnosed type 2 diabetes. Here, INS is linked to type 2 diabetes mellitus.